• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLR7 激动剂 R848 通过靶向不变自然杀伤 T 细胞产生 IFN-γ来缓解过敏炎症。

The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.

机构信息

Université Paris Descartes, Faculté de Médecine-Centre National de la Recherche Scientifique Unité Mixte de Recherche 8147, Hôpital Necker, Paris, France.

出版信息

J Immunol. 2011 Jan 1;186(1):284-90. doi: 10.4049/jimmunol.1001348. Epub 2010 Dec 3.

DOI:10.4049/jimmunol.1001348
PMID:21131420
Abstract

It has been documented that TLR7 stimulation triggers not only antiviral responses, but also alleviates experimental asthma. Considering the implication of invariant NKT (iNKT) cells in both situations, we postulated that they might contribute to the anti-inflammatory effect of TLR7 ligands. We show in this study that spleen cells activated by the TLR7 agonist resiquimod (R848) attenuate allergic inflammation upon adoptive transfer when they are recovered from wild-type, but not from iNKT cell-deficient Jα18(-/-) mice, which proves the specific involvement of this regulatory population. Furthermore, we provide evidence that IFN-γ is critical for the protective effect, which is lost when transferred iNKT cells are sorted from IFN-γ-deficient mice. In support of a direct activation of iNKT cells through TLR7 signaling in vivo, we observed a prompt increase of serum IFN-γ levels, associated with upregulation of CD69 expression on iNKT cells. Moreover, we demonstrate that iNKT cells effectively express TLR7 and respond to R848 in vitro by producing high levels of IFN-γ in the presence of IL-12, consistent with the conclusion that their contribution to the alleviation of allergic inflammation upon treatment with TLR7 ligands is mediated through IFN-γ.

摘要

有文献记载 TLR7 刺激不仅能引发抗病毒反应,还能缓解实验性哮喘。鉴于不变自然杀伤 T(iNKT)细胞在这两种情况下的作用,我们假设它们可能有助于 TLR7 配体的抗炎作用。在这项研究中,我们发现 TLR7 激动剂瑞喹莫德(R848)激活的脾细胞在从野生型而非 iNKT 细胞缺陷型 Jα18(-/-)小鼠中回收时,通过过继转移可减轻过敏炎症,这证明了这种调节性群体的特异性参与。此外,我们提供的证据表明 IFN-γ 对于保护作用至关重要,当从 IFN-γ 缺陷型小鼠中转移的 iNKT 细胞被分选时,这种保护作用就会丧失。为了支持 TLR7 信号在体内直接激活 iNKT 细胞,我们观察到血清 IFN-γ 水平的迅速升高,同时 iNKT 细胞上 CD69 表达上调。此外,我们证明 iNKT 细胞在体外有效表达 TLR7,并在 IL-12 的存在下对 R848 产生高水平的 IFN-γ,这与它们通过 TLR7 配体治疗缓解过敏炎症的贡献是通过 IFN-γ 介导的结论一致。

相似文献

1
The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.TLR7 激动剂 R848 通过靶向不变自然杀伤 T 细胞产生 IFN-γ来缓解过敏炎症。
J Immunol. 2011 Jan 1;186(1):284-90. doi: 10.4049/jimmunol.1001348. Epub 2010 Dec 3.
2
Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms.TLR7 激动剂 R848 治疗可诱导调节性 T 细胞介导的已建立的哮喘症状抑制。
Eur J Immunol. 2011 Jul;41(7):1992-9. doi: 10.1002/eji.201040914. Epub 2011 Jun 6.
3
Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.在用不变自然杀伤T细胞配体治疗后,白细胞介素-27和干扰素-γ的产生负责在小鼠实验性哮喘模型中抑制Th2反应和过敏性炎症。
J Immunol. 2009 Jul 1;183(1):254-60. doi: 10.4049/jimmunol.0800520.
4
Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcγRIIIA-dependent mechanisms.前沿:静脉注射免疫球蛋白通过 FcγRIIIA 依赖性机制抑制不变自然杀伤 T 细胞介导的过敏性气道炎症。
J Immunol. 2011 Mar 15;186(6):3289-93. doi: 10.4049/jimmunol.1003076. Epub 2011 Feb 11.
5
Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.产生 IL-4 或 IL-10 而不是 IFN-γ的不变自然杀伤 T 细胞可抑制实验性自身免疫性脑脊髓炎中的 Th1 反应,而这些细胞均不抑制 Th17 反应。
J Immunol. 2011 Jun 15;186(12):6815-21. doi: 10.4049/jimmunol.1003916. Epub 2011 May 13.
6
A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation.不变自然杀伤 T 细胞在先天细胞驱动的肺部炎症小鼠模型中的天然保护功能。
Eur J Immunol. 2011 Feb;41(2):299-305. doi: 10.1002/eji.201040647. Epub 2011 Jan 11.
7
CD1d-restricted IFN-γ-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells.CD1d 限制性 IFN-γ 分泌 NKT 细胞通过调节巨噬细胞炎症蛋白-1α 的产生以及激活巨噬细胞和树突状细胞来促进免疫复合物诱导的急性肺损伤。
J Immunol. 2011 Feb 1;186(3):1432-41. doi: 10.4049/jimmunol.1003140. Epub 2010 Dec 29.
8
Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.通过TLR7和/或TLR8刺激的人树突状细胞可诱导初始CD4 + T细胞依次产生IL-10、IFN-γ和IL-17A。
J Immunol. 2009 Mar 15;182(6):3372-9. doi: 10.4049/jimmunol.0801969.
9
Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.不变自然杀伤 T 细胞优先调节 CD8α+树突状细胞亚群的功能,以诱导针对感染的 1 型免疫。
J Immunol. 2010 Feb 15;184(4):2095-106. doi: 10.4049/jimmunol.0901348. Epub 2010 Jan 20.
10
IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod).IL-27对于TLR7/8激动剂R848(瑞喹莫德)抑制实验性变应性哮喘至关重要。
J Immunol. 2016 Dec 1;197(11):4219-4227. doi: 10.4049/jimmunol.1601094. Epub 2016 Oct 31.

引用本文的文献

1
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.CAR-NKT 细胞在哮喘中的应用:NKT 作为 CAR 治疗有前途的细胞的应用。
Clin Rev Allergy Immunol. 2024 Jun;66(3):328-362. doi: 10.1007/s12016-024-08998-0. Epub 2024 Jul 12.
2
T-bet B cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity.T 细胞转录因子(T-bet)B 细胞在肥胖期间在脂肪组织中积累,并加剧代谢紊乱。
Cell Metab. 2022 Aug 2;34(8):1121-1136.e6. doi: 10.1016/j.cmet.2022.07.002. Epub 2022 Jul 21.
3
Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma.
干扰素-λ(IFNλ)及其受体在哮喘中的调控与功能。
Front Immunol. 2021 Nov 10;12:731807. doi: 10.3389/fimmu.2021.731807. eCollection 2021.
4
A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.一种拮抗免疫抑制作用的 TNFR2 抗体与 HMGN1 和 R848 免疫刺激剂协同抑制小鼠结肠癌。
Int Immunopharmacol. 2021 Dec;101(Pt A):108345. doi: 10.1016/j.intimp.2021.108345. Epub 2021 Nov 15.
5
drives the resolution of allergic asthma.推动过敏性哮喘的消退。
iScience. 2021 Sep 25;24(10):103163. doi: 10.1016/j.isci.2021.103163. eCollection 2021 Oct 22.
6
Interleukin-27 and Its Diverse Effects on Bacterial Infections.白细胞介素-27 及其对细菌感染的多种影响。
Front Immunol. 2021 May 17;12:678515. doi: 10.3389/fimmu.2021.678515. eCollection 2021.
7
R848 Is Involved in the Antibacterial Immune Response of Golden Pompano () Through TLR7/8-MyD88-NF-κB-Signaling Pathway.R848 通过 TLR7/8-MyD88-NF-κB 信号通路参与金黄鰤()的抗菌免疫反应。
Front Immunol. 2021 Jan 18;11:617522. doi: 10.3389/fimmu.2020.617522. eCollection 2020.
8
Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy. Toll 样受体激动剂作为变应原免疫治疗的佐剂。
Front Immunol. 2020 Nov 12;11:599083. doi: 10.3389/fimmu.2020.599083. eCollection 2020.
9
A Solid-in-Oil Nanodispersion System for Transcutaneous Immunotherapy of Cow's Milk Allergies.用于牛奶过敏经皮免疫治疗的油包固纳米分散体系
Pharmaceutics. 2020 Feb 27;12(3):205. doi: 10.3390/pharmaceutics12030205.
10
Food Allergies: Current and Future Treatments.食物过敏:当前和未来的治疗方法。
Medicina (Kaunas). 2019 May 1;55(5):120. doi: 10.3390/medicina55050120.